Trial Profile
Single Center, Randomized, Double-Blind, 3-Way Parallel Study to Compare the Pharmacokinetics, Safety and Tolerability of BMO-2 to EU and US Sourced Humira, Administered as a Single Dose (40 mg) Subcutaneous Injection in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jun 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Autoimmune disorders
- Focus Pharmacokinetics
- Sponsors Mylan
- 18 Jun 2015 New trial record